Jump to: How CagriSema works | The phase 3 trial results | How CagriSema compares to Mounjaro and Wegovy | Side effects and tolerability | UK availability and likely timeline | Who CagriSema might suit | Frequently asked questions | Take home message | References CagriSema is an investigational once-a-week weight-loss injection from Novo Nordisk that combines two drugs, cagrilintide and semaglutide
Chantelle often explains it to her clients this way: when your calories come down, protein needs to make up a bigger share of what you eat, so your body still has enough to support your muscle mass while you're losing weight
An interesting possibility for men: as body fat decreases, natural testosterone production may increase
CDC (2023) General Best Practice Guidelines for Immunization: Vaccine Administration Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides
These are medications based on a hormone your body already produces to regulate hunger and digestion